Comorbidity Status of Deceased of Covid-19 Patients in Malaysia

Abstract

There have been 35,737 fatalities and 4,544,626 confirmed cases of Covid-19 in Malaysia as of June 2022. Based on previous study, Covid-19 patients who have comorbidity are likely to have increased risk of fatality. In this regard, the present study is designed to collect preliminary data that prove the potential relationship between comorbidity and Covid-19 fatality in Malaysia. The data was extracted from Covid-19 official website (COVIDNOW) using Microsoft Excel. These comprises of number of deaths, number of cases, age, gender, and country of origin and any coexisting conditions. Results show that among 471 deceased of Covid-19 patients, 22.5% of them had no comorbidity while 77.5% of the mortality had comorbidities. This is led by hypertension as the top one (52.23%), followed by diabetes (36.73 %) and heart disease (15.71 %). This study highlights the potential link between comorbidity status and deceased Covid-19 patients in Malaysia. However, further in-dept research is still necessary to thoroughly understand the link between these two variables. These data signal the importance of proper Covid-19 management among patients with comorbidity.